KOREA ARLICO PHARM CO.,LTD.
Manufactures generic drugs and provides CDMO services to a global market.
260660 | KO
Overview
Corporate Details
- ISIN(s):
- KR7260660006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 바우뫼로27길 7-21 (양재동), 서초구
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Korea Arlico Pharm Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's operations are centered on the production and distribution of generic pharmaceuticals, including prescription (ETC) and over-the-counter (OTC) drugs, as well as a specialized Contract Development and Manufacturing Organization (CDMO) business for third-party clients. Its product portfolio addresses a range of therapeutic areas, including circulatory and digestive system disorders, anti-inflammatory analgesics, and hypertension. The company also develops and sells medical devices and active pharmaceutical ingredients. Operating from PIC/S GMP-certified facilities, Korea Arlico Pharm distributes its products in its domestic market and exports to numerous countries globally, positioning itself as a key domestic manufacturer with international reach.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 761.7 KB | ||
| 2025-06-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 116.0 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 679.2 KB | ||
| 2025-04-30 00:00 |
Regulatory News Service
소속부변경
|
Korean | 3.6 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 21.8 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 17.8 KB | ||
| 2025-03-20 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.1 MB | ||
| 2025-03-06 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 83.6 KB | ||
| 2025-02-26 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 5.7 KB | ||
| 2025-02-26 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 81.1 KB | ||
| 2025-02-25 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 11.0 KB | ||
| 2025-02-12 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.3 KB | ||
| 2025-02-12 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정
|
Korean | 9.1 KB | ||
| 2024-12-17 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 127.6 KB | ||
| 2024-12-13 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB |
Automate Your Workflow. Get a real-time feed of all KOREA ARLICO PHARM CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KOREA ARLICO PHARM CO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KOREA ARLICO PHARM CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}